Steven Cohen's CC Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.02 M shares of The Chemours Company (CC) worth $16.13 M, representing 0.03% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in CC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2018, adding 989,926 shares. Largest reduction occurred in Q2 2018, reducing 1.57 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's The Chemours Company (CC) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Chemours Company (CC) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2016 | +264,000 | New Buy | 264,000 | $16.00 |
| Q4 2016 | -264,000 | Sold Out | 0 | $0.00 |
| Q1 2017 | +831,405 | New Buy | 831,405 | $38.50 |
| Q2 2017 | -831,405 | Sold Out | 0 | $0.00 |
| Q3 2017 | +65,700 | New Buy | 65,700 | $50.61 |
| Q4 2017 | +578,258 | Add 880.15% | 643,958 | $50.06 |
| Q1 2018 | +989,926 | Add 153.73% | 1.63 M | $48.71 |
| Q2 2018 | -1.57 M | Reduce 96.36% | 59,500 | $44.35 |
| Q3 2018 | +160,471 | Add 269.70% | 219,971 | $39.44 |
| Q4 2018 | -219,971 | Sold Out | 0 | $0.00 |
| Q1 2019 | +341,911 | New Buy | 341,911 | $37.16 |
| Q2 2019 | -214,911 | Reduce 62.86% | 127,000 | $24.00 |
| Q3 2019 | +230,937 | Add 181.84% | 357,937 | $14.94 |
| Q4 2019 | -357,937 | Sold Out | 0 | $0.00 |
| Q1 2020 | +93,300 | New Buy | 93,300 | $8.87 |
| Q2 2020 | +614,999 | Add 659.16% | 708,299 | $15.35 |
| Q3 2020 | -708,299 | Sold Out | 0 | $0.00 |
| Q3 2021 | +17,500 | New Buy | 17,500 | $29.09 |
| Q4 2021 | -17,500 | Sold Out | 0 | $0.00 |
| Q4 2023 | +314,300 | New Buy | 314,300 | $31.54 |
| Q1 2024 | +131,792 | Add 41.93% | 446,092 | $26.26 |
| Q2 2024 | -419,046 | Reduce 93.94% | 27,046 | $22.57 |
| Q3 2024 | -27,046 | Sold Out | 0 | $0.00 |
| Q4 2024 | +334,070 | New Buy | 334,070 | $16.90 |
| Q1 2025 | -334,070 | Sold Out | 0 | $0.00 |
| Q2 2025 | +331,662 | New Buy | 331,662 | $11.45 |
| Q3 2025 | +686,874 | Add 207.10% | 1.02 M | $15.84 |
Steven Cohen's The Chemours Company Investment FAQs
Steven Cohen first purchased The Chemours Company (CC) in Q3 2016, acquiring 264,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held The Chemours Company (CC) for 27 quarters since Q3 2016.
Steven Cohen's largest addition to The Chemours Company (CC) was in Q1 2018, adding 1,633,884 shares worth $79.59 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,018,536 shares of The Chemours Company (CC), valued at approximately $16.13 M.
As of the Q3 2025 filing, The Chemours Company (CC) represents approximately 0.03% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in The Chemours Company (CC) was 1,633,884 shares, as reported at the end of Q1 2018.